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ABSTRACT 
Background. Spinal Bifida is a congenital malformation of the spine that typified 
defect of the neural tube with devastating neurological, psychosocial and 
developmental burden to the growing child with associated huge financial burden to 
the parents, community and the country. Past and present studies have shown 
strong evidence to indicate that folic acid supplementation during the 
periconceptional period reduces the occurrence of spinal bifida in children.  
Aim. To assess the knowledge, attitude, and practice of use of folic acid during the 
periconceptional period among women of childbearing age in two rural communities 
in Edo State, Nigeria.  
Materials and methods. A prospective cross-sectional study of 170 women between 
the ages of 15 and 49 years recruited through a multi-stage sampling technique. The 
survey instrument was a structured interviewer-administered questionnaire. The 
data was analysed using Statistical Package for Social Sciences (SPSS) version 21 and 
presented as charts, tables, and associations tested with Chi-square at a statistical 
level of significance set at p<0.05.  
Results. One hundred and twenty-two (71.8%) of the respondents showed good 
knowledge, 147(86.5%) had a positive attitude, and 106 (62.4%) had a good practice 
of use of folic acid. There was a statistically significant association between 
respondents’ age, marital status, level of education, occupation, and their knowledge 
of the use of folic acid as well as with their attitude towards the use of folic acid. 
However, the practice was mainly associated with the socio-demographic variable of 
each household.  
Conclusion. The use of folic acid during the perinatal period for the prevention of  
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spinal bifida is found to be absent in about two-fifths of the 
study population, a number found to be alarming despite the 
high level of good knowledge and attitude towards the use of 
folic acid. There is, therefore, an urgent need to step up more 
advocacy and health education to women of childbearing age 
to increase the uptake of folic acid for effective reduction of the 
incidence of spinal bifida. 
 
INTRODUCTION 
Spinal bifida is part of a group of birth defects called 
neural tube defects (NTDs) which are caused by the 
abnormal closure of the embryonic neural tube 
between 22 and 28 days after conception.1 The 
neural tube is the embryonic structure that 
eventually develops into the baby’s brain and spinal 
cord as well as adjacent tissues. There are two major 
types of spinal bifida: spinal bifida occulta as seen 
when the vertebral defect or malformation is 
covered by skin and hence hidden, and spinal bifida 
cystic characterized by a cystic protrusion. Spinal 
bifida cystic is further subdivided into meningocele 
in which the protrusion contains meninges and 
cerebrospinal fluid, and may or may not be covered 
by skin or myelomeningocele is the most severe 
form where the protrusion which contains spinal 
cord and nerves is exposed to the exterior.2 The 
worldwide incidence of spinal bifida varies between 
0.17 and 6.39 per 1000 live-births.3 In Nigeria, 
however, the general incidence of neural tube 
defects has been reported at rates of 2.75 to 7 per 
1000 livebirths.4,5 
Past and ongoing studies have shown that the 
use of folic acid has significantly reduced the 
occurrence of spinal bifida and other neural tube 
defects. The relationship between apparent folate 
deficiency and spinal bifida was hypothesized as 
early as 1965. This prompted the conduction of 
randomized control trials by the medical research 
council where they found that women with the 
previous history of NTD-related pregnancies 
reduced the risk of occurrence by 70% by taking 4000 
micrograms of folic acid daily. In 1984, Hungarian 
randomized control trial found 100% reduction in 
risk of having the first occurrence of NTD-affected 
pregnancy among women who took 800 micrograms 
of folic acid daily 6,7 although the exact mechanism by 
which folic acid prevents spina bifida, and other 
NTDs is still not known, its role in the synthesis, 
repair, and methylation of DNA especially in rapidly 
growing cells is instructive. The world health 
organization recommends that all women of 
childbearing age consume 400 micrograms of folic 
daily and that women with pregnancies previously 
affected by NTDs consume 5000 micrograms of folic 
acid daily.8 Women should consume these amounts 
in the periconceptional period as it takes eight weeks 
to reach the optimal serum level of folic acid.9 
 
METHODOLOGY 
This is an eight-month (June 2017 to January 2018) 
prospective cross-sectional study involving 170 
women of child bearing age attending the Primary 
Health Care Facility at Usugbenu and Opoji, Edo 
Central Senatorial District, Edo State, Nigeria. This 
study was carried out by the use of an interviewer-
administered questionnaire with emphasis on the 
following areas: Knowledge of use of folic acid in the 
prevention of spinal bifida among women of child 
bearing age, compliance to use of folic acid among 
women of childbearing age, and factors that 
influence use of folic acid among women of child 
bearing age.  
Data were analyzed using SPSS version 21. 
Descriptive and inferential statistics were used to 
describe and interpret the data with the level of 
statistical significance set at p<0.05.  
 
RESULTS 
Majority of the respondents 90 (52.9%) were 
between age 30-39, while only 5 (2.9%) were less 
than 20 years. All the respondents 170 (100%) were 
females. Those married were 131 (77.1%) while 4 
(2.4%) were cohabiting. A total of 84 (49.4%) 
respondents had secondary education, while 34 
(20%) has primary education. Most of the 
respondents 79(46.5%) were self-employed while 
6(3.5%) were students. Most of the respondents had 
been pregnant 70(41.2%) while a total of 19(11.2%) 
had not been pregnant before. (TABLE 1). 
Majority 127 (74.7%) have not had Spinal bifida 
child, while 43 (25.3%) have had a Spinal bifida child 
in the past (FIGURE 1). Seventy-nine (46.5%) said they 
had had a Miscarriage while 91(53.5%) said they had 
not had any Miscarriage (FIGURE 2).  
In scoring for “KNOWLEDGE,” 11 points were 
considered from the questionnaire, and a score of > 
7 points was graded as “GOOD,” a score of 5 -7 was 
graded as “FAIR,” while a score of < 5 was graded as 
“POOR.” In scoring for “ATTITUDE,” 8 points were 
considered from the questionnaire, and a score of >4 
was graded as “POSITIVE,” while a score of ≤ 4 was 
 202 Eghosa Morgan, Nosa Akpede, Emmanuel Friday Osagiede et al. 
graded as “NEGATIVE.” In scoring for “PRACTICE,” 6 
points were considered from the questionnaire, and 
a score of >3 was graded as “GOOD,” a score 2 -3 was 
graded as “FAIR” while a score of < 2 was graded as 
“POOR.” In scoring for “DETERMINANTS,” 5 points 
were considered from the questionnaire, and if > 2 
“NO” were ticked, it was graded as “STRONG” while if 
≤ 2 “NO” were ticked it was graded as “WEAK” (TABLE 
2). 
There was a statistically significant relationship 
between age group, marital status, level of 
education, occupation, number of pregnancies had 
and spinal bifida. However, there was no statistically 
significant relationship with the number of 
miscarriage (TABLE 3A). There was a statistically 
significant relationship between, level of education 
and occupation. However, there was no statistically 
significant relationship with age group, spinal bifida 
child, pregnancies had, marital status and 
miscarriage (TABLE 3B). There was a statistically 
significant relationship between age-group, marital 
status, level of education and number of pregnancies 
had. However, there was no statistically significant 
relationship with having spinal bifida child (TABLE 5). 
There was a statistically significant relationship 
between age group and occupation, but there is no 
statistically marital status, level of education, 
number of pregnancies had, spinal bifida child and 
miscarriages (TABLE 7). 
 
 
TABLE 1. Socio-demographic characteristics of respondents. 
 
VARIABLE  FREQUENCY (n=170) PERCENT (%) 
Age group(year)    
< 20 5 2.9 
20-29 46 27.1 
30-39 90 52.9 
40-49 29 17.1 
Mean ± SD = 28.41±0.73   
Marital status   
Single 21 12.4 
Married 131 77.1 
Widowed 14 8.2 
Co-habiting 4 2.4 
Level of education   
Primary 34 20.0 
Secondary 84 49.4 
Tertiary 52 30.6 
Occupation   
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FIGURE 1. Prevalence of spinal bifida. 
 
 
 
FIGURE 2. Prevalence of Miscarriages. 
 
 
43(25.3%)
127( 74.7%)
Percentage
Aware Not aware
79 (46.5%)
91(53.5%)
Had Miscarriage
Yes No
Employed 58 34.1 
Unemployed 27 15.9 
Self-employed 79 46.5 
Student 6 3.5 
Pregnancies had   
None 19 11.2 
1-3 39 22.9 
4-6 70 41.2 
7-9 35 20.6 
>9 7 4.1 
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TABLE 2. Respondents knowledge, attitude, practices, and determinants in the use of folic acid in the prevention of spinal bifida. 
 
 
TABLE 3A. Association between socio-demographic characteristics of respondents and their knowledge on the use of folic acid in 
the prevention of spina bifida. 
 
Variable Frequency (n=170) Percent (%) 
Knowledge   
Good 122 71.8 
Fair 36 21.2 
Poor 12 7.1 
Attitude    
Positive 147 86.5 
Negative 23 13.5 
Practice    
Good 106 62.4 
Fair 49 28.8 
Poor 15 8.8 
Determinants   
Strong 9 5.3 
Weak 161 94.7 
DEMOGRAPHIC  KNOWLEDGE OF RESPONDENT 
VARIABLE GOOD (%) FAIR (%) POOR (%) TOTAL (%) 
Age group (years)      
< 20 1(20) 2(40) 2(40) 5(100) 
20-29 27(58.7) 14(30.4) 5(10.9) 46(100) 
30-39 74(82.2) 12(13.3) 4(4.5) 90(100) 
40-49 20(70) 8(27.6) 1(2.4) 29(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =  20.280   p=0.002     
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TABLE 3B. Socio-demographic characteristics of respondents and knowledge on the use of folic acid in the prevention of spinal 
bifida. 
 
Marital status      
Single 8(38.1) 6(28.6) 7(33.3) 21(100) 
Married 98(74.8) 28(21.4) 5(3.8) 131(100) 
Widowed 12(85.7) 2(14.3) 0(0) 14(100) 
Cohabiting 4(100) 0(0) 0(0) 4(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =  29.775   p<0.001     
Level of education     
Primary 22(64.6) 4(11.8) 8(23.6) 34(100) 
Secondary 56(66.6) 26(31) 2(2.4) 84(100) 
Tertiary 44(84.7) 6(11.5) 2(3.8) 52(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =  25.662   p<0.0001     
Occupation     
Employed 48(82.8) 8(13.8) 2(3.4) 58(100) 
Unemployed 13(48.2) 8(29.6) 6(22.2) 27(100) 
Self-employed 58(73.4) 18(22.8) 3(3.8) 79(100) 
Student 3(50.1) 2(33.3) 1(16.6) 6(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =18.262 p= 0.006     
DEMOGRAPHIC VARIABLES KNOWLEDGE OF RESPONDENT 
Pregnancies had GOOD (%) FAIR (%) POOR (%) TOTAL (%) 
None 11(57.9) 3(15.8) 5(26.3) 19(100) 
1-3 24(61.5) 11(28.2) 4(10.3) 39(100) 
4-6 53(75.7) 15(21.4) 2(2.9) 70(100) 
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TABLE 4A. Sociodemographic characteristics of respondents and attitude on the use of folic acid in the prevention of spina bifida. 
 
7-9 28(80) 7(20) 0(0) 35(100) 
>9 6(85.7) 0(0) 1(14.3) 7(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =19.714 p=0.011     
Had  Spinal bifida child     
Yes 39(90.7) 3(7) 1(2.3) 43(100) 
No 83(65.3) 33(26) 11(8.7) 127(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2 =10.182 p =0.006      
Had a Miscarriage      
Yes 61(77.2) 15(19) 3(3.8) 79(100) 
No 61(67.1) 21(23.1) 9(9.8) 91(100) 
Total 122(71.7) 36(21.2) 12(7.1) 170(100) 
X2=3.169,p=0.205     
DEMOGRAPHIC VARIABLE ATTITUDE OF RESPONDENT 
Age group (years) POSITIVE (%) NEGATIVE (%) TOTAL (%) 
< 20 3(60) 2(40) 5(100) 
20-29 38(82.6) 8(17.4) 46(100) 
30-39 82(91.1) 8(8.9) 90(100) 
40-49 24(82.8) 5(17.2) 29(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 =  5.579    p=0.134    
Marital status     
Single 15(71.4) 6(28.6) 21(100) 
Married 114(87) 17(13) 131(100) 
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Widowed 14(100) 0(0) 14(100) 
Cohabiting 4(100) 0(0) 4(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 =  6.912      p=0.075    
Level of education    
Primary 24(70.6) 10(29.4) 34(100) 
Secondary 73(86.9) 11(13.1) 84(100) 
Tertiary 50(96.2) 2(3.8) 52(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 =  11.512      p=0.003    
Occupation    
Employed 52(89.7) 6(10.3) 58(100) 
Unemployed 17(63) 10(37) 27(100) 
Self-employed 72(91.1) 7(8.9) 79(100) 
Student 6(100) 0(0) 6(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 =15.667 p=0.001    
Pregnancies had    
None 15(78.9) 4(21.1) 19(100) 
1-3 29(74.4) 10(25.6) 39(100) 
4-6 64(91.4) 6(8.6) 70(100) 
7-9 33(94.3) 2(5.7) 35(100) 
>9 6(85.7) 1(14.3) 7(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 = 9.111 p=0.058    
 208 Eghosa Morgan, Nosa Akpede, Emmanuel Friday Osagiede et al. 
TABLE 4B. Sociodemographic characteristics of respondents and attitude on the use of folic acid in the prevention of spinal bifida. 
 
 
TABLE 5A. Socio-demographic characteristics of respondents and practice on the use of folic acid in the prevention of spinal bifida. 
 
DEMOGRAPHIC VARIABLE ATTITUDE OF RESPONDENT 
Had  Spinal bifida child POSITIVE (%) NEGATIVE (%) TOTAL (%) 
Yes 38(88.4) 5(11.6) 43(100) 
No 109(85.8) 18(14.2) 127(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2 =0.178, p=0.673    
Had a Miscarriage     
Yes 70(88.6) 9(11.4) 79(100) 
No 77(85.6) 14(15.4) 91(100) 
Total 147(86.5) 23(13.5) 170(100) 
X2=0.576, p=0.448    
DEMOGRAPHIC VARIABLE PRACTICE OF RESPONDENT 
 GOOD (%) FAIR (%) POOR (%) TOTAL (%) 
Age group (years)      
< 20 1(20) 2(40) 2(40) 5(100) 
20-29 22(47.8) 16(34.8) 8(17.4) 46(100) 
30-39 64(71.1) 22(24.4) 4(4.4) 90(100) 
40-49 19(65.6) 9(31) 1(3.4) 29(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 =  17.821    p=0.007     
Marital status     
Single 8(38.1) 5(23.8) 8(38.1) 21(100) 
Married 82(62.6) 44(33.6) 5(3.8) 131(100) 
Widowed 12(85.7) 0(0) 2(14.3) 14(100) 
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Cohabiting 4(100) 0(0) 0(0) 4(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 =   35.461  p<0.001     
Level of education     
Primary 13(38.2) 17(50) 4(11.8) 34(100) 
Secondary 53(63) 26(31) 5(6) 84(100) 
Tertiary 40(77) 6(11.5) 6(11.5) 52(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 =17.314, p=0.002     
Occupation     
Employed 43(74.2) 9(15.5) 6(10.3) 58(100) 
Unemployed 10(37) 15(55.6) 2(7.4) 27(100) 
Self-employed 49(62) 23(29.1) 7(8.9) 79(100) 
Student 4(66.7) 2(33.3) 0(0) 6(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 =15.131 , p=0.019     
Pregnancies had     
None 8(42.1) 3(15.8) 8(42.1) 19(100) 
1-3 25(64.1) 10(25.6) 4(10.3) 39(100) 
4-6 41(58.5) 27(38.6) 2(2.9) 70(100) 
7-9 28(80) 7(20) 0(0) 35(100) 
>9 4(57.1) 2(28.6) 1(14.3) 7(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 = 37.809 p=0.000     
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TABLE 5B. Socio-demographic characteristics of respondents and practice on the use of folic acid in the prevention of spinal bifida. 
 
DEMOGRAPHIC VARIABLE PRACTICE OF RESPONDENT 
 GOOD (%) FAIR (%) POOR (%) TOTAL (%) 
Had  Spinal bifida     
Yes 32(74.4) 10(23.3) 1(2.3) 43(100) 
No 74(58.3) 39(30.7) 14(11) 127(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2 =4.717,  p=0.095     
Had a Miscarriage      
Yes 56(70.9) 22(27.8) 1(1.3) 79(100) 
No 50(54.9) 27(29.7) 14(15.4) 91(100) 
Total 106(62.4) 49(28.8) 15(8.8) 170(100) 
X2=11.326,p=0.003     
 
TABLE 6A. Socio-demographic characteristics of respondents and the determinants on the use of folic acid in the prevention of spinal 
bifida. 
 
DEMOGRAPHIC VARIABLE DETERMINANTS OF RESPONDENT 
 STRONG (%) WEAK (%) TOTAL (%) 
Age group (years)     
< 20 1(20) 4(80) 5(100) 
20-29 6(13) 40(87) 46(100) 
30-39 2(2.2) 88(97.8) 90(100) 
40-49 0(0) 29(100) 29(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2 =  10.981   p=0.012    
Marital status     
Single 3(14.3) 18(85.7) 21(100) 
Married 6(4.6) 125(95.4) 131(100) 
 211 The use of folic acid in the prevention of spinal bifida 
 
TABLE 6B. Socio-demographic characteristics of respondents and the determinants on the use of folic acid in the prevention of spinal 
bifida. 
 
Widowed 0(0) 14(100) 14(100) 
Cohabiting 0(0) 4(100) 4(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2 =  4.526, p=0.210    
Level of education    
Primary 2(5.9) 32(94.1) 34(100) 
Secondary 3(3.6) 81(96.4) 84(100) 
Tertiary 4(7.7) 48(92.3) 52(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2  =1.117 p= 0.572     
Occupation    
Employed 2(3.4) 56(96.6) 58(100) 
Unemployed 4(14.8) 23(85.2) 27(100) 
Self-employed 2(2.5) 77(97.5) 79(100) 
Student 1(16.7) 5(83.3) 6(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2 =80.26 p=0.045    
DEMOGRAPHIC VARIABLE DETERMINANTS OF RESPONDENT 
 STRONG (%) WEAK (%) TOTAL (%) 
Pregnancies had    
None 3(15.8) 16(84.2) 19(100) 
1-3 2(5.1) 37(94.9) 39(100) 
4-6 4(5.7) 66(94.3) 70(100) 
7-9 0(0) 35(100) 35(100) 
>9 0(0) 7(100) 7(100) 
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DISCUSSION 
This research was carried out to assess the 
knowledge, attitude, and practice of use of folic acid 
in the prevention of spinal bifida among women of 
childbearing age in ECLGA of Edo State. The research 
also assessed the relationship between socio-
demographic factors and knowledge and use of folic 
acid in the prevention of spinal bifida. A total of 170 
women, all of childbearing age, were interviewed. 
The mean age is 32 years with the highest proportion 
of participants 90(52.9%) consisting of those within 
the age group 30-39 years.  
Majority of the participants were married 
131(77.1%) as compared to singles 21(12.4%), 
widows 14(8.2%), cohabiting (2.4%). Up to 84(49.4%) 
had secondary education, 52(30.6%) had tertiary 
education, and 34(20.0%) had primary education. We 
observed that the majority of the respondents 71.8% 
had good knowledge about the use of folic acid in the 
prevention of spinal bifida. This is in sharp contrast 
to a study done on awareness of mothers about 
birth defects in Ibadan, in which only 15.8% knew 
that birth defects could be prevented.10 In another 
study in Ibadan, only 11.8% knew that folic acid could 
prevent birth defects although as much as 98.3% 
were using folic acid in the current pregnancy.11 
64.6% awareness of folic acid was reported in Jos.12 
In Port Harcourt, 94.4% knew about folic acid, but 
only 24.1% knew folic acid could prevent birth 
defects.13 The high awareness in this study is quite 
encouraging. It could be explained by the proximity 
of the respondents to a tertiary health facility (Irrua 
Specialist Teaching Hospital) which gives them 
access to health education through campaigns or 
interactions with resident health personnel. Also, 
there is routine education of women during 
antenatal visits, as most respondents stated.  
We also observed that certain socio-demographic 
factors had a demonstrable influence on knowledge 
of folic acid use in the prevention of spinal bifida. 
Age, marital status, level of education, occupation, 
previous pregnancy and having babies with spinal 
bifida in the past were significantly associated with 
knowledge of the use of folic acid whereas factors 
like religion and number of miscarriages were not. 
These observations are by earlier observations.11, 14-
18 On the aspect of attitude towards the use of folic 
acid, most of the respondents 86.5%. Showed a 
positive attitude. Sociodemographic factors 
significantly associated with this positive attitude 
were level of education (p=0.003), occupation 
(p=0.001). 
More than half of the respondents 62.4 had a 
good practice which compares favorably with the 
Total 9(5.3) 161(94.7) 170(100) 
X2 =6.549, p=0.162    
Had Spinal bifida child    
Yes 0(0) 43(100) 43(100) 
No 9(7.1) 118(92.9) 127(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2 =3.218, p=0.073    
Had Miscarriage     
Yes 4(5.1) 75(94.9) 79(100) 
No 5(5.9) 86(94.1) 91(100) 
Total 9(5.3) 161(94.7) 170(100) 
X2=0.016, p=0.900    
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result of the study done in Jakarta, Indonesia where 
64% of respondents claimed to have been compliant 
with the use of folic acid.33 In another study done in 
Canada, 71% were compliant with the use of folic 
acid,35 while only 22.3% of the women in a study in 
Denmark showed compliance19. The differences 
between our observation and between the results in 
previous reports could be due to the difficulty in 
measuring the actual practice of use of folic acid by 
women of childbearing age, for example in the 
Jakarta study20; two parallel results were obtained 
from the same respondents using qualitative and 
quantitative tools.  
There was a statistically significant relationship 
between age (p=0.007), number of miscarriages 
(p=0.003), marital status (p=0.000), level of education 
(p=0.002), number of pregnancies had (0.000). A 
number of pregnancies had the highest statistical 
significance.  
Determinants of use of folic acid showed 
statistically significant relationship with certain 
sociodemographic factors such as with age group 
such as women between 30-39 years had strong 
score while women less than 20 years had weak 
score reason for which may be due to teenage 
unplanned pregnancy, ignorance and late antenatal 
booking which is in keeping with the study done in 
South-western Nigeria.17 In our study, the occupation 
had the highest statistical significant relationship 
(p=0.045). This shows that employment empowers 
these women making them better placed to use folic 
acid. Also, employment is also related to an older 
age.  
 
CONCLUSION 
We concluded that  
1. The knowledge of the use of folic acid among 
women of childbearing age in ECLGA is good. 
Furthermore, attitude and practice of use of folic acid 
match the knowledge and compares unfavourably 
with the levels reported from other places.  
2. The level of knowledge, attitude, and practice on 
the use of folic acid among women of childbearing 
age in ECLGA are dependent on age, marital status, 
level of education, occupation, number of 
pregnancies, previous child with spinal bifida.  
 
RECOMMENDATION 
We recommend that: 
1. The government and health institution should 
work closely with stakeholders in the health sector to 
create more public enlightenment campaigns to 
increase awareness about spinal bifida and use of 
folic acid either in their diet or as medication in its 
prevention especially among women of childbearing 
age 
2. Communities should organize forums where a 
health worker enlightened member about the 
benefits of the use of folic acid by women of 
childbearing age while also answering any questions 
they may have. 
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